Matthias Braeutigam

Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis

Michael J. Meurer, Gisela Albrecht, Thomas Vogt et al. · Dermatology · 2004 · 99 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Evaluation of the Antipruritic Effects of Topical Pimecrolimus in Non-Atopic Prurigo Nodularis: Results of a Randomized, Hydrocortisone-Controlled, Double-Blind Phase II Trial

Dorothee Siepmann, Tobias Lotts, Christine Blome et al. · Dermatology · 2013 · 66 citations

Pharmacy, Dermatology, Pharmacotherapy +17

Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial

S. Weissenbacher, J. Merkl, Bernhard Hildebrandt et al. · British Journal of Dermatology · 2006 · 65 citations

Medicine, Dermatology, Pharmacotherapy +10

Pimecrolimus 1% Cream in the Treatment of Facial Psoriasis: A 16-Week Open-Label Study

Arnd Jacobi, Matthias Braeutigam, Vera Mahler et al. · Dermatology · 2008 · 44 citations

Medicine, Dermatology, Pharmacotherapy +15

Influence of Pimecrolimus Cream 1% on Different Morphological Signs of Eczema in Infants with Atopic Dermatitis

Kristine Breuer, Matthias Braeutigam, Alexander Kapp et al. · Dermatology · 2004 · 37 citations

Medicine, Dermatology, Immunology +17